J. Richard Miller

5.3k citations

35 papers · 1.6k indexed · h-index 22

Co-authors: Dale E. Edmondson John E. Cronan Michael A. MarlettaXin ZhaoA.G. Evdokimov Yanfang Jiang Grover L. Waldrop Gary W. Ashley
Topics: Biochemical and Molecular Research (6 papers)Metabolism and Genetic Disorders (4 papers)Cancer therapeutics and mechanisms (4 papers)
Cited by: Biochemistry Molecular Medicine Clinical Biochemistry
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States United Kingdom Poland

In The Last Decade

J. Richard Miller

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by J. Richard Miller

Since Specialization

Citations

This map shows the geographic impact of J. Richard Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Richard Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Richard Miller more than expected).

Fields of papers citing papers by J. Richard Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Richard Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Richard Miller. The network helps show where J. Richard Miller may publish in the future.

Co-authorship network of co-authors of J. Richard Miller

This figure shows the co-authorship network connecting the top 25 collaborators of J. Richard Miller. A scholar is included among the top collaborators of J. Richard Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Richard Miller. J. Richard Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates 2024 ·Organic Process Research & Development ·Osama Chahrour,Paul G. Bulger,Olivier Dirat,(unknown),Andrew T. Parsons,J. Gair Ford,Frank Bernardoni,Evan M. Hetrick,(unknown),Kevin P. Cole,J. Richard Miller,Qunying Zhang,Michael T. Jones	2
2	Risk Assessment and Control of N-Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices 2024 ·Organic Process Research & Development ·Paul G. Bulger,Michael T. Jones,J. Gair Ford,(unknown),Kevin P. Cole,Frank Bernardoni,Olivier Dirat,Qunying Zhang,Osama Chahrour,J. Richard Miller,(unknown),Andrew T. Parsons,(unknown)	2
3	Discovery of non-boronic acid Arginase 1 inhibitors through virtual screening and biophysical methods 2023 ·Bioorganic & Medicinal Chemistry Letters ·Symon Gathiaka,(unknown),Sung‐Sau So,Xiaomei Chai,J. Richard Miller,Reshma Kuvelkar,(unknown),(unknown),(unknown),Andy Liaw,David G. McLaren,Christian Fischer	2
4	Identification of Potent Reverse Indazole Inhibitors for HPK1 2021 ·ACS Medicinal Chemistry Letters ·(unknown),Joey L. Methot,Xavier Fradera,Charles A. Lesburg,Brian M. Lacey,Phieng Siliphaivanh,Ping Liu,Dustin Smith,Zangwei Xu,Jennifer Piesvaux,Shuhei Kawamura,Haiyan Xu,J. Richard Miller,Mark Bittinger,Alexander Pasternak	24
5	Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds 2021 ·ACS Medicinal Chemistry Letters ·Brandon Vara,Samuel M. Levi,(unknown),David A. Candito,Xavier Fradera,Charles A. Lesburg,Shuhei Kawamura,Brian M. Lacey,Jongwon Lim,Joey L. Methot,Zangwei Xu,Haiyan Xu,Dustin Smith,Jennifer Piesvaux,J. Richard Miller,Mark Bittinger,Sheila Ranganath,David Jonathan Bennett,Erin F. DiMauro,Alexander Pasternak	31
6	Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold 2021 ·Bioorganic & Medicinal Chemistry Letters ·Wensheng Yu,Yongqi Deng,David L. Sloman,Derun Li,Kun Liu,Xavier Fradera,Charles A. Lesburg,Theodore A. Martinot,Amy C. Doty,Heidi M. Ferguson,J. Richard Miller,Ian Knemeyer,Karin M. Otte,Stella Vincent,Nunzio Sciammetta,David Jonathan Bennett,Yongxin Han	6
7	Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma 2020 ·Cancer Immunology Research ·Handan Xiang,Carlo P. Ramil,Josephine Hai,Chunsheng Zhang,Huijun Wang,Amanda A. Watkins,Roshi Afshar,Peter Georgiev,Marc A. Sze,Xuelei S. Song,Patrick J. Curran,Mangeng Cheng,J. Richard Miller,Dongyu Sun,Andrey Loboda,Yanlin Jia,Lily Y. Moy,An Chi,Philip E. Brandish	190
8	Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice 2020 ·Toxicology and Applied Pharmacology ·Amy G. Aslamkhan,Qiuwei Xu,(unknown),(unknown),Stephen Pacchione,(unknown),(unknown),(unknown),Lisa LaFranco-Scheuch,Kara Pearson,(unknown),Nianyu Li,Heather Zhou,J. Richard Miller,Nicolas Solban,Alan Bass,Warren E. Glaab	6
9	Mg2+ regulation of kinase signaling and immune function 2019 ·The Journal of Experimental Medicine ·Chryssa Kanellopoulou,Alex George,Evan Masutani,Jennifer L. Cannons,Juan C. Ravell,Tori N. Yamamoto,Margery Smelkinson,Ping Jiang,Mami Matsuda‐Lennikov,Julie Reilley,Robin Handon,Ping‐Hsien Lee,J. Richard Miller,Nicholas P. Restifo,Lixin Zheng,Pamela L. Schwartzberg,Matthew A. Young,Michael J. Lenardo	57
10	Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma 2012 ·Neuro-Oncology ·William T. Phillips,Beth Goins,Ande Bao,(unknown),(unknown),A. Trevino,J. Richard Miller,Jack Henry,(unknown),Giacomo G. Vecil,A. J. Brenner	69
11	Evaluation of Pharmacokinetic/Pharmacodynamic Relationships of PD-0162819, a Biotin Carboxylase Inhibitor Representing a New Class of Antibacterial Compounds, Using In Vitro Infection Models 2011 ·Antimicrobial Agents and Chemotherapy ·Adam Ogden,Michael Kuhn,(unknown),(unknown),(unknown),Tong Zhu,Deqing Xiao,J. Richard Miller,Debra Hanna	3
12	The Use of Biochemical and Biophysical Tools for Triage of High‐Throughput Screening Hits – A Case Study with Escherichia coli Phosphopantetheine Adenylyltransferase 2010 ·Chemical Biology & Drug Design ·J. Richard Miller,V. Thanabal,Michael Melnick,Manjinder S. Lall,(unknown),Ronald W. Sarver,(unknown),Jeffrey F. Ohren,D.W. Emerson	24
13	Discovery of novel antibacterials 2010 ·Expert Opinion on Drug Discovery ·J. Richard Miller,Grover L. Waldrop	28
14	Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim 2009 ·Proteins Structure Function and Bioinformatics ·H. Heaslet,Melissa S. Harris,Kelly Fahnoe,Ronald W. Sarver,(unknown),Jeanne S. Chang,Chakrapani Subramanyam,Gabriela Barreiro,J. Richard Miller	98
15	Structural evidence for substrate‐induced synergism and half‐sites reactivity in biotin carboxylase 2008 ·Protein Science ·Igor Mochalkin,J. Richard Miller,A.G. Evdokimov,Sandra Lightle,Chunhong Yan,C. Kendall Stover,Grover L. Waldrop	67
16	Streptococcus pneumononiae gyrase ATPase: Development and validation of an assay for inhibitor discovery and characterization 2007 ·Analytical Biochemistry ·J. Richard Miller,John T. Herberg,(unknown),(unknown),(unknown)	8
17	The Reaction of LipB, the Octanoyl-[Acyl Carrier Protein]:Protein N-Octanoyltransferase of Lipoic Acid Synthesis, Proceeds through an Acyl-Enzyme Intermediate 2005 ·Biochemistry ·Xin Zhao,J. Richard Miller,John E. Cronan	51
18	Assembly of the Covalent Linkage between Lipoic Acid and Its Cognate Enzymes 2003 ·Chemistry & Biology ·Xin Zhao,J. Richard Miller,Yanfang Jiang,Michael A. Marletta,John E. Cronan	119
19	Influence of Flavin Analogue Structure on the Catalytic Activities and Flavinylation Reactions of Recombinant Human Liver Monoamine Oxidases A and B 1999 ·Journal of Biological Chemistry ·J. Richard Miller,Dale E. Edmondson	29
20	Some properties of an adenosine triphosphatase obtained from beef corneal epithelium 1970 ·Canadian Journal of Physiology and Pharmacology ·(unknown),J. Richard Miller,(unknown)	2

About J. Richard Miller

J. Richard Miller is a scholar working on Biological Psychiatry, Structural Biology and Biochemistry, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Metabolism and Genetic Disorders (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Biochemistry (323 citations), Molecular Medicine (124 citations) and Clinical Biochemistry (103 citations). J. Richard Miller has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Dale E. Edmondson, John E. Cronan, Michael A. Marletta, Xin Zhao, A.G. Evdokimov, Yanfang Jiang, Grover L. Waldrop, Gary W. Ashley, Jennifer Cheek and Brian M. Lacey. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact